Circulating interleukin‐15 and RANTES chemokine in Parkinson’s disease
Identifieur interne : 001100 ( Main/Exploration ); précédent : 001099; suivant : 001101Circulating interleukin‐15 and RANTES chemokine in Parkinson’s disease
Auteurs : M. Rentzos ; C. Nikolaou [Grèce] ; E. Andreadou ; G. P. Paraskevas ; A. Rombos ; M. Zoga [Grèce] ; A. Tsoutsou [Grèce] ; F. Boufidou [Grèce] ; E. Kapaki ; D. VassilopoulosSource :
- Acta Neurologica Scandinavica [ 0001-6314 ] ; 2007-12.
English descriptors
- KwdEn :
Abstract
Interleukin‐15 promotes T‐cell proliferation, induction of cytolytic effector cells including natural killer (NK) and cytotoxic cells and stimulates B‐cell to proliferate and secrete immunoglobulins. RANTES is a C‐C beta chemokine with strong chemoattractant activity for T lymphocytes and monocytes. Objectives – The objective of our study was to find out whether IL‐15 and RANTES are involved in the possible inflammatory reactions of PD. Patients and methods – We measured by immunoassay serum IL‐15 and RANTES levels in 41 patients with PD in comparison with serum levels in 19 healthy subjects age and sex‐matched. IL‐15 and RANTES levels were correlated with sex, age, disease duration. H‐Y stage and the UPDRS III score in all the studied groups and were also correlated with treatment status in PD patients. Results – The PD group presented with significantly increased RANTES levels as compared to the control group (P = 0.0009). No difference was observed as regards IL‐15 levels. A strong and significant correlation between RANTES levels and UPDRS III score was observed in PD patients (Rs = 0.42, P = 0.007). Untreated patients had significantly higher RANTES levels as compared to the controls. Conclusions – Our findings may suggest a recruitment of activated monocytes, macrophages and T lymphocytes to sites of inflammation in the central nervous system of PD patients.
Url:
DOI: 10.1111/j.1600-0404.2007.00894.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Circulating interleukin‐15 and RANTES chemokine in Parkinson’s disease</title><author><name sortKey="Rentzos, M" sort="Rentzos, M" uniqKey="Rentzos M" first="M." last="Rentzos">M. Rentzos</name></author><author><name sortKey="Nikolaou, C" sort="Nikolaou, C" uniqKey="Nikolaou C" first="C." last="Nikolaou">C. Nikolaou</name></author><author><name sortKey="Andreadou, E" sort="Andreadou, E" uniqKey="Andreadou E" first="E." last="Andreadou">E. Andreadou</name></author><author><name sortKey="Paraskevas, G P" sort="Paraskevas, G P" uniqKey="Paraskevas G" first="G. P." last="Paraskevas">G. P. Paraskevas</name></author><author><name sortKey="Rombos, A" sort="Rombos, A" uniqKey="Rombos A" first="A." last="Rombos">A. Rombos</name></author><author><name sortKey="Zoga, M" sort="Zoga, M" uniqKey="Zoga M" first="M." last="Zoga">M. Zoga</name></author><author><name sortKey="Tsoutsou, A" sort="Tsoutsou, A" uniqKey="Tsoutsou A" first="A." last="Tsoutsou">A. Tsoutsou</name></author><author><name sortKey="Boufidou, F" sort="Boufidou, F" uniqKey="Boufidou F" first="F." last="Boufidou">F. Boufidou</name></author><author><name sortKey="Kapaki, E" sort="Kapaki, E" uniqKey="Kapaki E" first="E." last="Kapaki">E. Kapaki</name></author><author><name sortKey="Vassilopoulos, D" sort="Vassilopoulos, D" uniqKey="Vassilopoulos D" first="D." last="Vassilopoulos">D. Vassilopoulos</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:03FF5EC8029B79260FBE4840C78DAF918F6737DC</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1111/j.1600-0404.2007.00894.x</idno><idno type="url">https://api.istex.fr/document/03FF5EC8029B79260FBE4840C78DAF918F6737DC/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002540</idno><idno type="wicri:Area/Main/Curation">002206</idno><idno type="wicri:Area/Main/Exploration">001100</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Circulating interleukin‐15 and RANTES chemokine in Parkinson’s disease</title><author><name sortKey="Rentzos, M" sort="Rentzos, M" uniqKey="Rentzos M" first="M." last="Rentzos">M. Rentzos</name><affiliation><wicri:noCountry code="no comma">Departments of Neurology</wicri:noCountry></affiliation></author><author><name sortKey="Nikolaou, C" sort="Nikolaou, C" uniqKey="Nikolaou C" first="C." last="Nikolaou">C. Nikolaou</name><affiliation wicri:level="1"><country xml:lang="fr">Grèce</country><wicri:regionArea>Biopathology‐Immunology, School of Medicine, Athens National University, Aeginition Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Andreadou, E" sort="Andreadou, E" uniqKey="Andreadou E" first="E." last="Andreadou">E. Andreadou</name><affiliation><wicri:noCountry code="no comma">Departments of Neurology</wicri:noCountry></affiliation></author><author><name sortKey="Paraskevas, G P" sort="Paraskevas, G P" uniqKey="Paraskevas G" first="G. P." last="Paraskevas">G. P. Paraskevas</name><affiliation><wicri:noCountry code="no comma">Departments of Neurology</wicri:noCountry></affiliation></author><author><name sortKey="Rombos, A" sort="Rombos, A" uniqKey="Rombos A" first="A." last="Rombos">A. Rombos</name><affiliation><wicri:noCountry code="no comma">Departments of Neurology</wicri:noCountry></affiliation></author><author><name sortKey="Zoga, M" sort="Zoga, M" uniqKey="Zoga M" first="M." last="Zoga">M. Zoga</name><affiliation wicri:level="1"><country xml:lang="fr">Grèce</country><wicri:regionArea>Biopathology‐Immunology, School of Medicine, Athens National University, Aeginition Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Tsoutsou, A" sort="Tsoutsou, A" uniqKey="Tsoutsou A" first="A." last="Tsoutsou">A. Tsoutsou</name><affiliation wicri:level="1"><country xml:lang="fr">Grèce</country><wicri:regionArea>Biopathology‐Immunology, School of Medicine, Athens National University, Aeginition Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Boufidou, F" sort="Boufidou, F" uniqKey="Boufidou F" first="F." last="Boufidou">F. Boufidou</name><affiliation wicri:level="1"><country xml:lang="fr">Grèce</country><wicri:regionArea>Biopathology‐Immunology, School of Medicine, Athens National University, Aeginition Hospital, Athens</wicri:regionArea><wicri:noRegion>Athens</wicri:noRegion></affiliation></author><author><name sortKey="Kapaki, E" sort="Kapaki, E" uniqKey="Kapaki E" first="E." last="Kapaki">E. Kapaki</name><affiliation><wicri:noCountry code="no comma">Departments of Neurology</wicri:noCountry></affiliation></author><author><name sortKey="Vassilopoulos, D" sort="Vassilopoulos, D" uniqKey="Vassilopoulos D" first="D." last="Vassilopoulos">D. Vassilopoulos</name><affiliation><wicri:noCountry code="no comma">Departments of Neurology</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Neurologica Scandinavica</title><idno type="ISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2007-12">2007-12</date><biblScope unit="volume">116</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="374">374</biblScope><biblScope unit="page" to="379">379</biblScope></imprint><idno type="ISSN">0001-6314</idno></series><idno type="istex">03FF5EC8029B79260FBE4840C78DAF918F6737DC</idno><idno type="DOI">10.1111/j.1600-0404.2007.00894.x</idno><idno type="ArticleID">ANE894</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6314</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Elisa</term><term>IL‐15</term><term>L‐dopa treatment</term><term>Parkinson’s disease</term><term>RANTES</term><term>immunological disturbances</term><term>serum</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Interleukin‐15 promotes T‐cell proliferation, induction of cytolytic effector cells including natural killer (NK) and cytotoxic cells and stimulates B‐cell to proliferate and secrete immunoglobulins. RANTES is a C‐C beta chemokine with strong chemoattractant activity for T lymphocytes and monocytes. Objectives – The objective of our study was to find out whether IL‐15 and RANTES are involved in the possible inflammatory reactions of PD. Patients and methods – We measured by immunoassay serum IL‐15 and RANTES levels in 41 patients with PD in comparison with serum levels in 19 healthy subjects age and sex‐matched. IL‐15 and RANTES levels were correlated with sex, age, disease duration. H‐Y stage and the UPDRS III score in all the studied groups and were also correlated with treatment status in PD patients. Results – The PD group presented with significantly increased RANTES levels as compared to the control group (P = 0.0009). No difference was observed as regards IL‐15 levels. A strong and significant correlation between RANTES levels and UPDRS III score was observed in PD patients (Rs = 0.42, P = 0.007). Untreated patients had significantly higher RANTES levels as compared to the controls. Conclusions – Our findings may suggest a recruitment of activated monocytes, macrophages and T lymphocytes to sites of inflammation in the central nervous system of PD patients.</div></front></TEI><affiliations><list><country><li>Grèce</li></country></list><tree><noCountry><name sortKey="Andreadou, E" sort="Andreadou, E" uniqKey="Andreadou E" first="E." last="Andreadou">E. Andreadou</name><name sortKey="Kapaki, E" sort="Kapaki, E" uniqKey="Kapaki E" first="E." last="Kapaki">E. Kapaki</name><name sortKey="Paraskevas, G P" sort="Paraskevas, G P" uniqKey="Paraskevas G" first="G. P." last="Paraskevas">G. P. Paraskevas</name><name sortKey="Rentzos, M" sort="Rentzos, M" uniqKey="Rentzos M" first="M." last="Rentzos">M. Rentzos</name><name sortKey="Rombos, A" sort="Rombos, A" uniqKey="Rombos A" first="A." last="Rombos">A. Rombos</name><name sortKey="Vassilopoulos, D" sort="Vassilopoulos, D" uniqKey="Vassilopoulos D" first="D." last="Vassilopoulos">D. Vassilopoulos</name></noCountry><country name="Grèce"><noRegion><name sortKey="Nikolaou, C" sort="Nikolaou, C" uniqKey="Nikolaou C" first="C." last="Nikolaou">C. Nikolaou</name></noRegion><name sortKey="Boufidou, F" sort="Boufidou, F" uniqKey="Boufidou F" first="F." last="Boufidou">F. Boufidou</name><name sortKey="Tsoutsou, A" sort="Tsoutsou, A" uniqKey="Tsoutsou A" first="A." last="Tsoutsou">A. Tsoutsou</name><name sortKey="Zoga, M" sort="Zoga, M" uniqKey="Zoga M" first="M." last="Zoga">M. Zoga</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001100 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001100 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:03FF5EC8029B79260FBE4840C78DAF918F6737DC
|texte= Circulating interleukin‐15 and RANTES chemokine in Parkinson’s disease
}}
| This area was generated with Dilib version V0.6.23. |  |